Search research articles
Contact Us
Filters
Showing results (371-380 of 470) with videos related to
Page
of 47
Sort By:
The Lancet. Digital Health
|
June 2, 2023
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study
Maliazurina B Saad, Lingzhi Hong, Muhammad Aminu, et al.
Physical Review Letters
|
September 16, 2000
Search for CP violation in B+/- --> J/psiK+/- and B+/- --> psi(2S)K+/- decays
G Bonvicini, D Cinabro, S McGee, et al.
Nature Communications
|
February 1, 2020
Comprehensive T cell repertoire characterization of non-small cell lung cancer
Alexandre Reuben, Jiexin Zhang, Shin-Heng Chiou, et al.
Nature
|
October 22, 2025
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade
Adam J Grippin, Christiano Marconi, Sage Copling, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Nature Medicine
|
March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Cancer Discovery
|
April 17, 2023
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
Marcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti, et al.
Physical Review Letters
|
August 27, 2011
Observation of the h(c)(1P) Using e+ e- collisions above the DD threshold
T K Pedlar, D Cronin-Hennessy, J Hietala, et al.
Physical Review Letters
|
April 16, 2013
First measurement of the form factors in the decays D0 → ρ- e+ ν(e) and D+ → ρ0 e+ ν(e)
S Dobbs, Z Metreveli, K K Seth, et al.
Physical Review Letters
|
March 5, 2009
Observation of eta' decays to pi+pi-pi0 and pi+pi-e+e-
P Naik, J Rademacker, D M Asner, et al.
Page
of 47
Search research articles
Search
Showing results (371-380 of 470) with videos related to
Sort By:
Page
of 47
The Lancet. Digital Health
|
June 2, 2023
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study
Maliazurina B Saad, Lingzhi Hong, Muhammad Aminu, et al.
Physical Review Letters
|
September 16, 2000
Search for CP violation in B+/- --> J/psiK+/- and B+/- --> psi(2S)K+/- decays
G Bonvicini, D Cinabro, S McGee, et al.
Nature Communications
|
February 1, 2020
Comprehensive T cell repertoire characterization of non-small cell lung cancer
Alexandre Reuben, Jiexin Zhang, Shin-Heng Chiou, et al.
Nature
|
October 22, 2025
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade
Adam J Grippin, Christiano Marconi, Sage Copling, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Nature Medicine
|
March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Cancer Discovery
|
April 17, 2023
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
Marcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti, et al.
Physical Review Letters
|
August 27, 2011
Observation of the h(c)(1P) Using e+ e- collisions above the DD threshold
T K Pedlar, D Cronin-Hennessy, J Hietala, et al.
Physical Review Letters
|
April 16, 2013
First measurement of the form factors in the decays D0 → ρ- e+ ν(e) and D+ → ρ0 e+ ν(e)
S Dobbs, Z Metreveli, K K Seth, et al.
Physical Review Letters
|
March 5, 2009
Observation of eta' decays to pi+pi-pi0 and pi+pi-e+e-
P Naik, J Rademacker, D M Asner, et al.
Page
of 47